Perez-Simón, Jose Antonio <br/><br/>
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.  [electronic resource] 

 -  Haematologica  Apr 2013 
 - 526-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2012.065599  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Combined Modality Therapy<br/>Cyclosporine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Graft vs Host Disease--etiology<br/>Hematologic Neoplasms--mortality<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Infections--chemically induced<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--administration & dosage<br/>Prospective Studies<br/>Sirolimus--administration & dosage<br/>Survival Rate<br/>Tacrolimus--administration & dosage<br/>Time Factors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Unrelated Donors<br/>Young Adult